Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1139 Virotherapy with CodaLytic™, a codon-modified influenza virus, induces an anti-tumor immune microenvironment across preclinical models with different immune contextures
Compose a Response to This Article
Other responses
No responses have been published for this article.